Terms: = Head and neck cancer AND CTNNB1, P35222, 1499, ENSG00000168036, CTNNB AND Prognosis
22 results:
1. Targeted next-generation sequencing of Japanese patients with sinonasal mucosal melanomas identifies frequent NRAS and ctnnb1 mutations.
Tsushima N; Kano S; Hatanaka KC; Suzuki T; Hamada S; Idogawa H; Nakamaru Y; Suzuki M; Hatanaka Y; Homma A
Auris Nasus Larynx; 2024 Apr; 51(2):313-319. PubMed ID: 37953090
[TBL] [Abstract] [Full Text] [Related]
2. Missed cancer in the Danish head and neck cancer fast-track program: results from a tertiary cancer center.
Schmidt IG; Korsholm M; Johansen J; Sørensen JA; Godballe C; Bjørndal K
Acta Oncol; 2023 Aug; 62(8):836-841. PubMed ID: 37493617
[TBL] [Abstract] [Full Text] [Related]
3. SCand1 Reverses Epithelial-to-Mesenchymal Transition (EMT) and Suppresses Prostate cancer Growth and Migration.
Eguchi T; Csizmadia E; Kawai H; Sheta M; Yoshida K; Prince TL; Wegiel B; Calderwood SK
Cells; 2022 Dec; 11(24):. PubMed ID: 36552758
[TBL] [Abstract] [Full Text] [Related]
4. Identification of m6A-Related Biomarkers Associated with prognosis of Colorectal cancer.
Zhang Z; Zhang X
Med Sci Monit; 2021 Aug; 27():e932370. PubMed ID: 34373442
[TBL] [Abstract] [Full Text] [Related]
5. Prognostic and clinical implications of c-erbB-2 expression in patients with oral cancer: A meta-analysis.
Meng Y; Yang P; Ma L
Medicine (Baltimore); 2020 Jun; 99(23):e20575. PubMed ID: 32502026
[TBL] [Abstract] [Full Text] [Related]
6. MicroRNA‑200a promotes esophageal squamous cell carcinoma cell proliferation, migration and invasion through extensive target genes.
Yang B; Liu Y; Li L; Deng H; Xian L
Mol Med Rep; 2020 May; 21(5):2073-2084. PubMed ID: 32323771
[TBL] [Abstract] [Full Text] [Related]
7. MALAT1 rs619586 polymorphism functions as a prognostic biomarker in the management of differentiated thyroid carcinoma.
Wang ML; Liu JX
J Cell Physiol; 2020 Feb; 235(2):1700-1710. PubMed ID: 31456244
[TBL] [Abstract] [Full Text] [Related]
8. Poorly differentiated thyroid carcinoma : An underdiagnosed entity.
Dettmer MS; Schmitt A; Komminoth P; Perren A
Pathologe; 2020 Jun; 41(Suppl 1):1-8. PubMed ID: 31273418
[TBL] [Abstract] [Full Text] [Related]
9. [Poorly differentiated thyroid carcinoma : An underdiagnosed entity. German version].
Dettmer MS; Schmitt A; Komminoth P; Perren A
Pathologe; 2019 May; 40(3):227-234. PubMed ID: 31093689
[TBL] [Abstract] [Full Text] [Related]
10. The first postoperative-stimulated serum thyroglobulin is a prognostic factor for thyroid microcarcinomas.
Amui IO; Tagliarini JV; Castilho EC; Marques MA; Kiy Y; Corrente JE; Mazeto GMFS
Braz J Otorhinolaryngol; 2019; 85(1):37-42. PubMed ID: 29157630
[TBL] [Abstract] [Full Text] [Related]
11. Salivary epithelial-myoepithelial carcinoma: clinical, morphological and molecular features.
De Cecio R; Cantile M; Fulciniti F; Botti G; Foschini MP; Losito NS
Pathologica; 2017 Mar; 109(1):1-8. PubMed ID: 28635988
[TBL] [Abstract] [Full Text] [Related]
12. Mutation analysis of ctnnb1 gene and the ras pathway genes KRAS, NRAS, BRAF, and PIK3CA in eyelid sebaceous carcinomas.
Kwon MJ; Nam ES; Cho SJ; Park HR; Min SK; Seo J; Choe JY
Pathol Res Pract; 2017 Jun; 213(6):654-658. PubMed ID: 28551389
[TBL] [Abstract] [Full Text] [Related]
13. Genetic polymorphisms of Wnt/β-catenin pathway genes are associated with the efficacy and toxicities of radiotherapy in patients with nasopharyngeal carcinoma.
Yu J; Huang Y; Liu L; Wang J; Yin J; Huang L; Chen S; Li J; Yuan H; Yang G; Liu W; Wang H; Pei Q; Guo C
Oncotarget; 2016 Dec; 7(50):82528-82537. PubMed ID: 27769064
[TBL] [Abstract] [Full Text] [Related]
14. Decreased expression of CDH1 or ctnnb1 affects poor prognosis of patients with esophageal cancer.
Ishiguro H; Wakasugi T; Terashita Y; Sakamoto N; Tanaka T; Mizoguchi K; Sagawa H; Okubo T; Takeyama H
World J Surg Oncol; 2016 Sep; 14(1):240. PubMed ID: 27600761
[TBL] [Abstract] [Full Text] [Related]
15. Laryngeal Squamous Intraepithelial Lesions: An Updated Review on Etiology, Classification, Molecular Changes, and Treatment.
Gale N; Gnepp DR; Poljak M; Strojan P; Cardesa A; Helliwell T; Šifrer R; Volavšek M; Sandison A; Zidar N
Adv Anat Pathol; 2016 Mar; 23(2):84-91. PubMed ID: 26849814
[TBL] [Abstract] [Full Text] [Related]
16. Ultra-deep targeted sequencing of advanced oral squamous cell carcinoma identifies a mutation-based prognostic gene signature.
Chen SJ; Liu H; Liao CT; Huang PJ; Huang Y; Hsu A; Tang P; Chang YS; Chen HC; Yen TC
Oncotarget; 2015 Jul; 6(20):18066-80. PubMed ID: 25980437
[TBL] [Abstract] [Full Text] [Related]
17. Oncogenes and tumor suppressor genes in squamous cell carcinoma of the tongue in young patients.
Knopf A; Lempart J; Bas M; Slotta-Huspenina J; Mansour N; Fritsche MK
Oncotarget; 2015 Feb; 6(5):3443-51. PubMed ID: 25633809
[TBL] [Abstract] [Full Text] [Related]
18. Genetic gains and losses in oral squamous cell carcinoma: impact on clinical management.
Ribeiro IP; Marques F; Caramelo F; Pereira J; Patrício M; Prazeres H; Ferrão J; Julião MJ; Castelo-Branco M; de Melo JB; Baptista IP; Carreira IM
Cell Oncol (Dordr); 2014 Feb; 37(1):29-39. PubMed ID: 24353162
[TBL] [Abstract] [Full Text] [Related]
19. LOH at PDCD4, ctnnb1, and CASP4 loci contributes to stage progression of oral cancer.
Scapoli L; Girardi A; Rubini C; Martinelli M; Spinelli G; Palmieri A; Lo Muzio L; Carinci F
Int J Immunopathol Pharmacol; 2011; 24(2 Suppl):89-93. PubMed ID: 21781452
[TBL] [Abstract] [Full Text] [Related]
20. Glioma-associated oncogene family zinc finger 1 expression and metastasis in patients with head and neck squamous cell carcinoma treated with radiation therapy (RTOG 9003).
Chung CH; Dignam JJ; Hammond ME; Klimowicz AC; Petrillo SK; Magliocco A; Jordan R; Trotti A; Spencer S; Cooper JS; Le QT; Ang KK
J Clin Oncol; 2011 Apr; 29(10):1326-34. PubMed ID: 21357786
[TBL] [Abstract] [Full Text] [Related]
[Next]
